R&D News | pharmaphorum

News

Closeup of X-ray photography of human brain

Biogen, Eisai hit hard as Alzheimer’s drug is abandoned

The dwindling number of amyloid-targeting drugs in development for Alzheimer’s disease (AD) has been reduced by one more, after Biogen and Eisai pulled the plug on aducanumab.

News

UK biotech industry booms on record investment - analysis

UK biotech is booming, with the number of R&D companies increasing 65% since 2016 amid soaring annual investment of more than £2 billion, according to a new report.

News

Alexion signs R&D deals with two Nordic biotechs

Alexion has signed a deal with two Nordic biotechs to bolster its pipeline of potential rare disease drugs.

News

UK pharma patents up 20%, new report finds

The pharma industry saw double-digit growth in patent filings for the second year in a row in 2018, with applications from the UK up by a fifth, according to the latest

News

Packaged Pills in aluminium blisters stacked on each other

Seven future blockbuster drugs to look out for in 2019

AbbVie’s rheumatoid arthritis drug upadacitinib is at the top of a new list of drugs due to launch this year that are expected to make blockbuster sales by 2023.

News